Clinical Trial Update: Long-term Study to Evaluate Safety and Persistence of GF-CART01

View source ↗

Summary

This clinical trial update describes a long-term safety and persistence study of GF-CART01, with enrollment not yet starting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• High-grade B-cell Lymphoma
• Mediastinal Large B-cell Lymphoma

Drugs mentioned

• GF-CART01

Snippet

Sponsor: GenomeFrontier Therapeutics TW Co., Ltd. | Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma (FL) | Status: NOT_YET_RECRUITING